Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
dc.contributor.author | Wellens J. | |
dc.contributor.author | Edmans M. | |
dc.contributor.author | Obolski U. | |
dc.contributor.author | McGregor C.G.C. | |
dc.contributor.author | Simmonds P. | |
dc.contributor.author | Turner M. | |
dc.contributor.author | Jarvis L. | |
dc.contributor.author | Skelly D. | |
dc.contributor.author | Dunachie S. | |
dc.contributor.author | Barnes E. | |
dc.contributor.author | Eyre D.W. | |
dc.contributor.author | Colombel J.F. | |
dc.contributor.author | Wong S.Y. | |
dc.contributor.author | Klenerman P. | |
dc.contributor.author | Lindsay J.O. | |
dc.contributor.author | Satsangi J. | |
dc.contributor.author | Thompson C.P. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2023-06-18T17:45:04Z | |
dc.date.available | 2023-06-18T17:45:04Z | |
dc.date.issued | 2022-09-01 | |
dc.identifier.citation | Gut Vol.71 No.9 (2022) , 1919-1922 | |
dc.identifier.doi | 10.1136/gutjnl-2021-326312 | |
dc.identifier.eissn | 14683288 | |
dc.identifier.pmid | 34911744 | |
dc.identifier.scopus | 2-s2.0-85133845265 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/85602 | |
dc.rights.holder | SCOPUS | |
dc.subject | Medicine | |
dc.title | Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease | |
dc.type | Letter | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133845265&origin=inward | |
oaire.citation.endPage | 1922 | |
oaire.citation.issue | 9 | |
oaire.citation.startPage | 1919 | |
oaire.citation.title | Gut | |
oaire.citation.volume | 71 | |
oairecerif.author.affiliation | KU Leuven– University Hospital Leuven | |
oairecerif.author.affiliation | University of Oxford | |
oairecerif.author.affiliation | Scottish National Blood Transfusion Service | |
oairecerif.author.affiliation | Barts and The London School of Medicine and Dentistry | |
oairecerif.author.affiliation | Icahn School of Medicine at Mount Sinai | |
oairecerif.author.affiliation | Mahidol University | |
oairecerif.author.affiliation | Nuffield Department of Medicine | |
oairecerif.author.affiliation | John Radcliffe Hospital | |
oairecerif.author.affiliation | Tel Aviv University | |
oairecerif.author.affiliation | University of Oxford Medical Sciences Division | |
oairecerif.author.affiliation | Warwick Medical School |